share_log

Nocopi Technologies Enters Into Private Placement to Further Increase Cash Position

Nocopi Technologies Enters Into Private Placement to Further Increase Cash Position

Nocopi Technologies进入私募以进一步增加现金头寸
GlobeNewswire ·  2022/08/05 06:35

Approves 1-for-10 Reverse Stock Split to Enable Completion of Funding

批准10股1股的反向股票拆分,以完成融资

KING OF PRUSSIA, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Nocopi Technologies, Inc. (OTC Pink: NNUP), a developer of specialty reactive inks today announced that on August 1, 2022 the company entered into a stock purchase agreement ("Purchase Agreement") in connection with a private placement for total gross proceeds of $3.5 million. The Purchase Agreement provides for the issuance of an aggregate of 2,500,000 shares of the Company's common stock to two investors at a purchase price of $1.40 per share, as adjusted for the Company's contemplated one-for-ten (1:10) reverse stock split of the Company's common stock, par value $0.01 per share. The shares to be sold in the Purchase Agreement were priced at-the-market based on the volume weighted average price of Nocopi shares of approximately $0.14 during the 21-day period ending on July 29, 2022. In connection with this transaction, Nocopi did not incur any placement fees or commissions.

宾夕法尼亚州普鲁士国王,2022年8月5日(Global Newswire)--特种活性油墨开发商Nocopi Technologies,Inc.(场外交易粉色代码:NNUP)今天宣布,该公司于2022年8月1日签署了一项与私募有关的股票购买协议(“购买协议”),总收益为350万美元。购买协议规定以每股1.40美元的收购价向两名投资者发行总计2500,000股公司普通股,这是根据公司预期的普通股十分之一(1:10)反向股票拆分进行调整的,每股面值0.01美元。购买协议中将要出售的股票是根据截至2022年7月29日的21天期间Nocopi股票的成交量加权平均价约0.14美元按市场定价的。在这笔交易中,Nocopi没有产生任何配售费用或佣金。

"Over the last four years, our financial discipline has allowed us to eliminate all long-term debt while prudently growing the business and increasing our cash levels. Following the closing of the Purchase Agreement, we will be further positioned to pursue organic and strategic growth opportunities. We are excited to embark on a new phase of growth at Nocopi, supported by our enhanced board of directors and shareholders and a potentially very robust balance sheet that will allow us to actively pursue a variety of opportunities to expand our business. We remain focused on growing intrinsic value per share," said Chairman and CEO Michael Feinstein.

董事长兼首席执行官迈克尔·范斯坦表示:“在过去四年中,我们的财务纪律使我们能够消除所有长期债务,同时谨慎地发展业务并增加我们的现金水平。收购协议完成后,我们将进一步定位于寻求有机和战略增长机会。我们很高兴能在我们加强的董事会和股东以及潜在的非常稳健的资产负债表的支持下,开启Nocopi增长的新阶段。这将使我们能够积极寻求各种机会来扩大我们的业务。我们仍然专注于增长每股内在价值,”董事长兼首席执行官迈克尔·范斯坦说。

In connection with the Purchase Agreement, on August 1, 2022, the Company entered into a registration rights agreement, which provides that on or prior to August 1, 2023, the Company must file a registration statement to register the shares of common stock purchased pursuant to the Purchase Agreement.

关于购买协议,本公司于2022年8月1日签订了一份登记权协议,其中规定,在2023年8月1日或之前,本公司必须提交登记声明,登记根据购买协议购买的普通股股份。

The closing of the Purchase Agreement is subject to the occurrence of the reverse stock split and the Company's satisfaction of certain additional conditions. There is no guarantee that the closing of the Purchase Agreement will occur.

收购协议的完成取决于反向股票拆分的发生以及公司是否满足某些额外条件。不能保证购买协议将会完成。

1-for-10 Reverse Split
To enable the private placement transaction, the Board of Directors has approved a 1-for-10 (1:10) reverse stock split of its common stock. The effective date of the reverse stock split is Friday, August 26, 2022. Pursuant to the reverse stock split, Nocopi shareholders will receive one (1) new share of common stock for every ten (10) shares held prior to the effective date. Any fractional shares will be rounded up to the next whole share.

10中1反向拆分
为了实现私募交易,董事会已批准对其普通股进行10股1股(1:10)的反向股票拆分。反向股票拆分的生效日期为2022年8月26日(星期五)。根据反向股票拆分,Nocopi股东在生效日期前每持有十(10)股普通股,将获得一(1)股新普通股。任何零碎股份都将四舍五入为下一个完整股份。

On August 5, 2022, the Company filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission that contains additional information relating to the Purchase Agreement, registration rights agreement, and the reverse stock split. The Current Report on Form 8-K is available at www.sec.gov.

2022年8月5日,该公司向美国证券交易委员会提交了一份8-K表格的最新报告,其中包含与购买协议、注册权协议和反向股票拆分相关的更多信息。表格8-K的最新报告可在www.sec.gov上查阅。

About Nocopi Technologies ()
Nocopi develops and markets specialty reactive inks for unique, mess-free applications in the entertainment, toy and educational product markets. Nocopi also develops and markets document and product authentication technologies designed to combat fraudulent document reproduction, product counterfeiting and/or unauthorized product diversion. Nocopi derives revenue from technology licensing agreements as well as from the sale of its proprietary inks and other products to licensees and/or their licensed printers. Nocopi's products and systems include trade secrets as well as patented technologies.

关于Nocopi Technologies()
Nocopi开发和销售特种活性油墨,用于娱乐、玩具和教育产品市场上独特的、无脏乱的应用。Nocopi还开发和销售文件和产品认证技术,旨在打击欺诈性文件复制、产品假冒和/或未经授权的产品转移。Nocopi的收入来自技术许可协议以及向被许可人和/或其获得许可的印刷商出售其专有油墨和其他产品。Nocopi的产品和系统包括商业秘密和专利技术。

Safe Harbor for Forward-Looking Statements
This release may contain projections and other "forward-looking statements" relating to Nocopi's business, that are often identified by the use of "believes," "expects" or similar expressions. Forward-looking statements involve a number of estimates, assumptions, risks and uncertainties that may cause actual results to differ materially from those anticipated. Forward-looking statements may address uncertainties regarding customer preferences or demand for products incorporating Nocopi technology that underlie the company's revenue expectations, the company's ability to develop new products and new product applications, the financial condition of customers and the timeliness of their payments, the impact of fluctuations in currencies, global trade and shipping markets, etc. Actual results could differ from those projected due to numerous factors and uncertainties, and Nocopi can give no assurance that such statements will prove to be correct nor that Nocopi's actual results of ‎operations, financial condition and performance will not differ materially from those reflected or implied by its forward-‎looking statements. Investors should refer to the risk factors outlined in Nocopi's Form 10-K, Form 10-Q and other SEC reports available at www.sec.gov. Forward-looking statements are made as of the date of this news release; Nocopi assumes no obligation to update these statements.

前瞻性陈述的避风港
本新闻稿可能包含与Nocopi公司业务有关的预测和其他“前瞻性陈述”,这些陈述通常通过使用“相信”、“预期”或类似的表述来识别。前瞻性陈述涉及许多估计、假设、风险和不确定因素,这些估计、假设、风险和不确定因素可能导致实际结果与预期的大不相同。前瞻性表述可能涉及客户偏好或对采用Nocopi技术的产品的需求的不确定性,这些不确定性构成了公司的收入预期、公司开发新产品和新产品应用的能力、客户的财务状况及其付款的及时性、货币波动的影响、全球贸易和航运市场等。由于许多因素和不确定因素,实际结果可能与预期的不同,而且NOCOPi不能保证这些表述被证明是正确的,也不能保证NOCOPI的‎业务、财务状况和业绩的实际结果与其前瞻性‎表述中反映或暗示的结果不会有实质性的差异。投资者应参考诺科比公司的Form 10-K、Form 10-Q和其他美国证券交易委员会报告中概述的风险因素,这些报告可在www.sec.gov上获得。截至本新闻稿发布之日,这些陈述都是前瞻性陈述;Nocopi公司不承担更新这些陈述的义务。

Twitter – Investors: @NNUP_IR

推特-投资者:@NNUP_IR

Investor & Media Contacts
Chris Eddy or David Collins
Catalyst IR
212-924-9800
nnup@catalyst-ir.com

投资者和媒体联系人
克里斯·埃迪或大卫·柯林斯
催化剂红外光谱
212-924-9800
邮箱:nnup@Catalyst-ir.com


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发